Better Long-Term Buy: Eli Lilly or Viking Therapeutics?

Billionaire investor Warren Buffett has said in the past that "the stock market is a device for transferring money from the impatient to the patient." While it's easy to get caught up in chasing today's hottest trends and growth stocks, the biggest gains often come from being patient and willing to hold on for the long haul. It may not be exciting, and it can be frustrating many times, but if you find a high-quality stock, you can set yourself on a path to generate terrific gains.The most exciting opportunity in healthcare these days is in the GLP-1 market, where many companies are developing weight-loss drugs that could generate billions in revenue. Below, I'll look at two promising stocks in this space: Eli Lilly (NYSE: LLY), which is a behemoth with a strong track record, and Viking Therapeutics (NASDAQ: VKTX), which is much smaller in valuation but may have tremendous upside.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool